Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1

Gastric cancer (GC) is a leading cause of death worldwide and in urgent need of targeted drug development. In the current, we investigated the ability of a repositioned drug verteporfin (VP), originally a treatment for macular degeneration, to inhibit GC cell growth. VP inhibited growth of various G...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Myoung-Hee, Jeong, Gi Seok, Smoot, Duane T., Ashktorab, Hassan, Hwang, Chang Mo, Kim, Byung Sik, Kim, Hee Sung, Park, Yun-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716775/
https://www.ncbi.nlm.nih.gov/pubmed/29228735
http://dx.doi.org/10.18632/oncotarget.21946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716775/
https://www.ncbi.nlm.nih.gov/pubmed/29228735
http://dx.doi.org/10.18632/oncotarget.21946

Ejemplares similares